Chad Mirkin named Chemistry World Entrepreneur of the Year


Chad Mirkin
We are pleased to announce that Chad Mirkin, of Northwestern University, in Evanston in the US, has been named Chemistry World Entrepreneur of the Year 2013. He is the first non-UK researcher to receive the title, which acknowledges an individual’s contribution to the commercialisation of chemistry research.

In particular, the award recognises Mirkin’s development and successful commercialisation of spherical nucleic acids. These globular forms of DNA and RNA have been licensed for hundreds of products, including new diagnostic tools for cancer screening, and gene therapy drugs. Mirkin is director of Northwestern University’s International Institute for Nanotechnology, and is a member of President Obama’s Council of Advisors on Science and Technology. He has more than 900 patents to his name and has founded four spin-out companies.

The £4000 prize is awarded every year by the Royal Society of Chemistry. Past winners include Paul Workman (2012), Karl Coleman (2011) and Hagan Bayley (2009).

Don’t miss our upcoming feature, which will take a detailed look at Mirkin and his work.


Related Content

No small success

12 June 2013 Premium contentFeature

news image

Chad Mirkin has spun out his nanotechnology research into several companies

Chemistry World podcast - July 2013

1 July 2013 Podcast | Monthly

news image

Hagan Bayley explains the scientific scope for 3D printing and Chad Mirkin introduces programmable DNA building blocks

Most Read

UC Davis chemist sentenced to four years over explosion

19 November 2014 News and Analysis

news image

Postdoc sentenced over attempt to make explosive device and reckless disposal of hazardous waste

Spanish fly

10 October 2013 Podcast | Compounds

news image

Helen Scales looks at cantharidin, the active ingredient in this famous aphrodisiac

Most Commented

Beetle behind breath test for bank notes

17 November 2014 Research

news image

Photonic crystal inks inspired by longhorn beetle could help to fight counterfeiting

Bayer wins race to buy Merck & Co consumer care

9 May 2014 Business

news image

$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company